Amalgamated Bank Decreases Holdings in Kenvue Inc. (NYSE:KVUE)

Amalgamated Bank reduced its position in Kenvue Inc. (NYSE:KVUE) by 1.5% in the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 435,361 shares of the company’s stock after selling 6,459 shares during the period. Amalgamated Bank’s holdings in Kenvue were worth $9,373,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. Beaumont Financial Advisors LLC lifted its holdings in shares of Kenvue by 3.0% in the fourth quarter. Beaumont Financial Advisors LLC now owns 17,532 shares of the company’s stock valued at $377,000 after purchasing an additional 509 shares in the last quarter. Pinnacle Bancorp Inc. raised its holdings in shares of Kenvue by 51.3% in the fourth quarter. Pinnacle Bancorp Inc. now owns 1,552 shares of the company’s stock worth $33,000 after acquiring an additional 526 shares during the last quarter. Dfpg Investments LLC lifted its position in shares of Kenvue by 2.3% in the fourth quarter. Dfpg Investments LLC now owns 26,659 shares of the company’s stock valued at $567,000 after acquiring an additional 589 shares in the last quarter. Mutual Advisors LLC lifted its position in shares of Kenvue by 6.1% in the fourth quarter. Mutual Advisors LLC now owns 10,606 shares of the company’s stock valued at $228,000 after acquiring an additional 612 shares in the last quarter. Finally, Baron Wealth Management LLC increased its position in Kenvue by 7.5% during the 4th quarter. Baron Wealth Management LLC now owns 12,915 shares of the company’s stock worth $278,000 after purchasing an additional 899 shares in the last quarter. 97.64% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of research analysts have issued reports on the stock. Royal Bank of Canada reduced their target price on shares of Kenvue from $25.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, February 9th. William Blair assumed coverage on Kenvue in a research report on Wednesday, April 3rd. They issued a “market perform” rating for the company. The Goldman Sachs Group started coverage on Kenvue in a research report on Friday, March 1st. They set a “neutral” rating and a $20.00 target price on the stock. Sanford C. Bernstein assumed coverage on Kenvue in a report on Thursday, April 11th. They issued an “underperform” rating and a $18.00 price target for the company. Finally, JPMorgan Chase & Co. cut their price objective on shares of Kenvue from $25.00 to $24.00 and set an “overweight” rating on the stock in a report on Friday, February 9th. One investment analyst has rated the stock with a sell rating, eight have issued a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and a consensus price target of $24.85.

Kenvue Stock Performance

Shares of KVUE stock traded up $0.08 during mid-day trading on Friday, reaching $19.20. The company’s stock had a trading volume of 15,941,057 shares, compared to its average volume of 15,351,688. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.78 and a current ratio of 1.12. The company’s 50 day simple moving average is $19.82 and its 200-day simple moving average is $20.11. Kenvue Inc. has a 12-month low of $17.82 and a 12-month high of $27.80.

Kenvue (NYSE:KVUE) last released its quarterly earnings data on Thursday, February 8th. The company reported $0.31 EPS for the quarter, beating the consensus estimate of $0.28 by $0.03. Kenvue had a return on equity of 15.62% and a net margin of 9.87%. The company had revenue of $3.67 billion for the quarter, compared to analyst estimates of $3.78 billion. Kenvue’s revenue for the quarter was down 2.7% compared to the same quarter last year. Research analysts predict that Kenvue Inc. will post 1.15 earnings per share for the current fiscal year.

Kenvue Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Wednesday, May 22nd. Shareholders of record on Wednesday, May 8th will be issued a $0.20 dividend. This represents a $0.80 dividend on an annualized basis and a yield of 4.17%. The ex-dividend date of this dividend is Tuesday, May 7th.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.